Senior Director Clinical Biomarkers, BioPharma Business Development

San Francisco, United StatesRemote

Responsibilities

 Lead translational medicine and clinical biomarker strategy across oncology programs
 Define and oversee biomarker plans supporting late-stage development in solid tumors
 Support development and lifecycle strategies that enable successful product
and build out new concepts for new data types as they are created.
 Establish and lead strategic collaborations with BioPharma partners, academic
 Represent the company in external scientific and clinical initiatives that shape the future
 Build productive external partnerships that accelerate innovation, evidence generation,
 Maintain strong credibility in the external scientific community, with the ability to

The ideal candidate will bring deep expertise in oncology drug development, biomarker
experience spanning Phase 1–3 studies and multiple
within the BioPharma space (Pharma Lab Services, BD partnerships) including assay
biomarker strategies are aligned with overall BioPharma BD needs.
biomarkers, digital pathology, radiomics, and AI/ML-enabled approaches.
 Work with the RWD, AI, and bioinformatics teams to develop use cases for existing data
 Advanced degree in a relevant scientific discipline; PhD, MD, DVM, or equivalent strongly preferred.
experience in translational medicine, clinical biomarker
experience in biomarker-driven clinical development and medical affairs
 Demonstrated success in building external scientific relationships and representing
 Strong record of scientific leadership, cross-functional collaboration, and strategic execution.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.

The pay range is listed and actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location.
Remote USA $248,100 — $310,100 USD
Compensation & Total Rewards
This range reflects a good-faith estimate of the base pay we reasonably expect to offer at the time of hire. Final compensation will vary based on experience, qualifications, and internal equity considerations.
This position is also eligible for additional compensation and
benefits through Natera’s robust Total Rewards program, including: •
Annual performance incentive bonus •
Long-term equity awards •
Comprehensive health benefits (medical, dental, vision) •
Generous paid time off and company holidays •
Compensation Range $248,100 — $310,100 USD OUR OPPORTUNITY
Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents.
Additionally, Natera employees and their immediate families receive free testing in addition to fertility care benefits. Other
benefits include pregnancy and baby bonding leave, 401k benefits, commuter

For more information, visit www.natera.com .
Link: https://www.natera.com/notice-of-data-collection-california-residents/
Please be advised that Natera will reach out to candidates with a @ natera.com email domain ONLY.

scientific, and organizational leadership across a broad oncology diagnostics portfolio. This
strategies across early- and late-stage BioPharma collaborations in support of Natera’s strategic
goals eg TOMR and surrogacy in collaboration with Natera’s lifecycle and clinical development teams.
therapeutic modalities, including immunotherapy, targeted therapy, and antibody-drug conjugates. Key Responsibilities
strategy, translational endpoints, data generation, data interpretation, publication
 Partner closely with clinical development, bioinformatics, medical affairs, regulatory,
diagnostics, and commercial teams to ensure assay development portfolio and
 Work with external partners on their Natera-supported translational research efforts to
help them leverage Natera capabilities to optimize the value of their projects: these may
include identifying novel targets, characterizing resistance mechanisms, developing